Stevens-Johnson syndrome – Diagnostics – Overview of Information and Clinical Research

Stevens-Johnson syndrome is a rare but serious skin reaction that typically requires immediate medical attention. Understanding how doctors identify this condition—and what tests may be needed—can help patients and their families recognize when urgent care is necessary and what to expect during the diagnostic process.

Introduction: Who Should Seek Diagnostics and When

Stevens-Johnson syndrome is a medical emergency that demands immediate attention. If you or someone you know develops a painful rash, especially after starting a new medication or having an infection, seeking medical care right away is critical. The condition can develop quickly, and early diagnosis significantly improves outcomes.^[1]

You should head to the emergency department if you notice certain warning signs. These include a circular rash that appears darker in the middle and lighter around the edges, particularly if it develops after taking a new medicine or having an infection. Other urgent symptoms include skin that becomes red, swollen, blistered, or begins peeling, along with difficulty breathing, wheezing, or swelling of the mouth, face, lips, tongue, or throat. These symptoms may indicate a severe reaction and require immediate hospital treatment.^[3]

It’s important to note that drug-induced reactions may occur while you’re taking a medication or up to two weeks after stopping it. This means that even if you’ve recently discontinued a medicine, new symptoms should still prompt immediate medical evaluation. Before you go to the hospital, if possible, gather all medications you’re currently taking—including over-the-counter drugs and prescriptions—as this information helps doctors identify what might have triggered the reaction.^[1]

⚠️ Important

Do not drive yourself to the emergency department if you suspect Stevens-Johnson syndrome. Ask a family member or friend to drive you, or call emergency services for an ambulance. Bring all your medications with you to help doctors identify the potential cause. Time is critical, and professional medical transport ensures you receive care if your condition worsens during the journey.

People who recently started taking certain medications are at higher risk and should be particularly alert to symptoms. These high-risk medications include antibiotics (especially sulfa drugs), anti-epileptic drugs such as lamotrigine and carbamazepine, allopurinol for gout, and certain anti-inflammatory painkillers. If you’ve begun any of these treatments and develop unusual symptoms, medical evaluation is essential.^[3]

In children, infections like colds, flu, cold sores, or glandular fever are more commonly responsible for Stevens-Johnson syndrome than medications. Parents should watch for warning signs if their child has been sick recently, especially if a rash develops along with fever and other symptoms.^[3]

Classic Diagnostic Methods for Stevens-Johnson Syndrome

Diagnosing Stevens-Johnson syndrome primarily relies on recognizing its characteristic appearance and understanding the patient’s recent medical history. When you arrive at the hospital, the doctor will first take a detailed history of your illness, asking about when symptoms began, what medications you’ve been taking, and whether you’ve had any recent infections. This conversation provides crucial clues about what might have triggered the reaction.^[2]

After gathering your medical history, the doctor will perform a thorough physical examination, looking closely at the skin lesions on your body. The pattern and appearance of these lesions are often distinctive enough to suggest Stevens-Johnson syndrome. The rash typically consists of circular patches that are darker in the middle and lighter around the outside, resembling a target. These lesions may be found on various parts of the body, though the palms, soles, back of the hands, and outer surfaces of the limbs are most commonly affected.^[3]^[4]

One simple but important test doctors may perform is called the Nikolsky sign. This involves rubbing the skin lightly to see if the top layer slips away from the lower layers. A positive Nikolsky sign—where the skin easily detaches with gentle pressure—indicates that the skin is undergoing necrolysis, which is the death and shedding of skin tissue. This finding strongly supports the diagnosis of Stevens-Johnson syndrome or its more severe form, toxic epidermal necrolysis.^[15]^[24]

To confirm the diagnosis and rule out other conditions, doctors typically perform a skin biopsy. This procedure involves removing a small sample of affected skin, which is then examined under a microscope in a laboratory. The biopsy can reveal characteristic changes that confirm Stevens-Johnson syndrome, including full-thickness death of the outer skin layer and the presence of specific types of inflammatory cells. This microscopic examination helps distinguish Stevens-Johnson syndrome from other conditions that might cause similar-looking rashes.^[1]^[10]

However, it’s important to understand that skin biopsy results can take several days to come back. Because Stevens-Johnson syndrome is a medical emergency that requires immediate treatment, doctors often begin care based on clinical appearance and history rather than waiting for biopsy confirmation. The characteristic look of the rash, combined with the patient’s recent medication use or infection history, is usually sufficient to start treatment.^[5]

Blood tests are another important part of the diagnostic workup. Doctors may order a complete blood count (CBC) to check your blood cell levels and a comprehensive metabolic panel (CMP) to assess organ function, particularly the kidneys and liver. These tests help evaluate how severely the condition is affecting your body and guide treatment decisions. Blood cultures may also be taken to check for infection, as secondary infections are a serious complication of Stevens-Johnson syndrome.^[2]

A urine sample may be collected and analyzed. This helps doctors assess kidney function and check for signs of involvement of the urinary tract, which can occur when the condition affects the mucous membranes lining the bladder and urethra.^[2]

Imaging studies may be ordered depending on your symptoms. A chest X-ray is commonly performed to check for pneumonia or other lung complications, as respiratory symptoms often accompany Stevens-Johnson syndrome. The respiratory system can be affected when the condition impacts the mucous membranes of the airways.^[1]^[10]

If doctors suspect an infection triggered the Stevens-Johnson syndrome rather than a medication, they may take samples of skin, tissue, or fluid for culture. These samples are sent to a laboratory where technicians try to grow and identify any bacteria, viruses, or other organisms that might be present. In children especially, infections with Mycoplasma pneumoniae (a type of bacteria that causes pneumonia) are a well-known trigger for Stevens-Johnson syndrome.^[1]^[9]

Eye examination using a specialized microscope called a slit lamp is crucial because Stevens-Johnson syndrome frequently affects the eyes. An eye specialist may check for damage to the eyelids, the surface of the eye, and the inside lining of the eyelids. Early detection of eye involvement allows doctors to begin protective treatments that can prevent long-term vision problems.^[4]

⚠️ Important

Stevens-Johnson syndrome has a characteristic appearance that experienced doctors can often recognize on sight. However, it must be distinguished from other conditions that cause similar symptoms, such as staphylococcal scalded skin syndrome, certain types of blistering diseases, and other drug reactions. This is why multiple diagnostic tests are performed—to ensure the correct diagnosis and appropriate treatment.

Doctors use a scoring system called SCORTEN to assess the severity of Stevens-Johnson syndrome and predict the risk of death. This system evaluates seven factors: age over 40 years, presence of cancer, extent of skin detachment, blood urea levels, blood glucose levels, blood bicarbonate levels, and heart rate. Each factor present adds one point to the score, and higher scores indicate greater risk. This helps medical teams determine the level of care needed and identify patients who require more intensive monitoring and treatment.^[13]

Diagnostics for Clinical Trial Qualification

Information about specific diagnostic criteria used for enrolling patients in clinical trials for Stevens-Johnson syndrome was not provided in the available sources. Clinical trials for rare and serious conditions like Stevens-Johnson syndrome typically have strict eligibility criteria to ensure patient safety and study validity, but the exact diagnostic tests and measurements required would vary depending on the specific trial protocol and the treatment being studied.

Prognosis and Survival Rate

Prognosis

The outlook for patients with Stevens-Johnson syndrome depends on several factors, including how quickly treatment begins, the extent of skin and mucous membrane involvement, the patient’s age, and overall health. Early recognition and immediate discontinuation of the triggering medication significantly improve outcomes. Patients who receive prompt care in specialized units, such as intensive care units or burn centers, generally have better results than those whose treatment is delayed.^[14]

Recovery from Stevens-Johnson syndrome takes time. The skin typically requires several weeks to heal, and patients often feel extremely tired for weeks after leaving the hospital. Even after the acute phase resolves, many survivors experience long-term complications. More than half of patients who survive toxic epidermal necrolysis—the severe form of the condition—suffer from lasting problems. These can include permanent vision impairment or blindness due to eye damage, chronic dry eye syndrome, scarring and changes in skin color, loss of nails that may not regrow, respiratory problems including asthma, difficulty swallowing, and psychological effects such as post-traumatic stress disorder.^[3]^[9]^[19]

Certain factors increase the risk of a poor outcome. Older patients, particularly those over 40 years of age, face higher risks. People with existing medical conditions such as cancer or weakened immune systems also tend to have worse outcomes. The extent of skin detachment is another critical factor—patients with larger areas of affected skin face greater risks of complications including fluid loss, infection, organ failure, and death.^[13]

Genetic factors play a role in who develops Stevens-Johnson syndrome. Certain human leukocyte antigen (HLA) types, which are markers of the immune system, have been linked to increased risk when taking specific medications. For example, people of Han Chinese descent who carry the HLA-B*1502 genetic marker face a much higher risk of developing Stevens-Johnson syndrome when taking carbamazepine, an anti-seizure medication. Asian Americans and South Asian Indians also have increased risk because of this genetic factor. This discovery has led to recommendations for genetic testing before prescribing certain high-risk medications in these populations.^[2]^[9]^[21]

Survival Rate

Stevens-Johnson syndrome is a life-threatening condition, though survival rates vary depending on the severity of the disease. For Stevens-Johnson syndrome, where less than 10% of body surface area is affected, the reported mortality rate ranges from 1% to 5%. This means that approximately 95% to 99% of patients with Stevens-Johnson syndrome survive with appropriate medical care.^[9]

The more severe form of the condition, called toxic epidermal necrolysis, has significantly higher mortality rates. When more than 30% of body surface area is affected, the average reported mortality rate is 25% to 35%, meaning survival rates range from 65% to 75%. In some cases, particularly among elderly patients and those with extensive skin detachment, the mortality rate can be even higher, reaching up to 80% in the most severe cases. This translates to survival rates as low as 20% for the most critically ill patients.^[9]^[23]

For cases that fall between Stevens-Johnson syndrome and toxic epidermal necrolysis—where 10% to 30% of body surface area is affected—the prognosis lies somewhere in the middle of these ranges. Recent studies have shown survival rates for Stevens-Johnson syndrome ranging from 71% to 80.6%, while toxic epidermal necrolysis survival rates range from 52% to 85.2%, depending on the patient population studied and the quality of care received.^[23]

It’s important to understand that these statistics represent averages, and individual outcomes depend on many factors including the speed of diagnosis and treatment, the patient’s overall health, the presence of complications, and the quality of supportive care provided. About 10% of all patients affected by the Stevens-Johnson syndrome spectrum may die from the disease.^[24]

Long-term survival also matters. Patients who survive the acute phase may face years of medical challenges. The condition can affect multiple body systems, requiring ongoing care from various specialists including dermatologists, ophthalmologists, and other doctors. Many survivors find they cannot return to work due to lingering complications, and some require long-term disability support.^[19]

#1 Clinical Trials Search in Europe